| . | Control (n = 18) . | Onset CD (n = 20) . |
|---|---|---|
| Age (years) | ||
| Mean (SD) | 30.7 (6.4) | 30.0 (15.5) |
| Median (1st-3rd Q) | 29.5 (26.8-32.2) | 26.0 (20.0-34.0) |
| Sex (M/F) | 3/15 | 8/12 |
| Harvey Index | – | 7.7 ± 3 |
| CRP [0-8 mg/L] | ||
| Mean (SD) | 1.4 (1.9) | 52.5 (47.9) |
| Median (1st-3rd Q) | 1 (0.7-1.4) | 47.0 (9.5-90.1) |
| Fibrinogen [170-437 mg/dL] | ||
| Mean (SD) | 318.4 (92.0) | 485.3 (79.2) |
| Median (1st-3rd Q) | 304.0 (247.8-338.0) | 485.0 (428.5-527.5) |
| Leukocytes [4.5-10.8 × 103/µL] | ||
| Mean (SD) | 5.8 (1.3) | 9.7 (5.9) |
| Median (1st-3rd Q) | 5.6 (4.8-6.4) | 8.6 (4.8-13.7) |
| Lymphocytes [2.0-11.0 × 103/µL] | ||
| Mean (SD) | 2.0 (0.4) | 1.8 (0.8) |
| Median (1st-3rd Q) | 2.0 (1.7-2.3) | 1.8 (1.1-2.3) |
| S/nS/eS | 4/14/0 | 7/12/1 |
| Clinical classification of CD (montreal classification) | ||
| A (age at diagnosis, years) | ||
| A1 (≤16) | 2 | |
| A2 (17–40) | 14 | |
| A3 (>40) | 4 | |
| L (location) | ||
| L1 (ileal) | 11 | |
| L2 (colonic) | 2 | |
| L3 (ileocolonic) | 7 | |
| L4 (upper GI disease) | 0 | |
| B (behaviour) | ||
| B1 (inflammatory) | 15 | |
| B2 (structuring) | 5 | |
| B3 (penetrating) | 0 | |
| P (perianal) | ||
| Yes | 5 | |
| No | 15 | |
| . | Control (n = 18) . | Onset CD (n = 20) . |
|---|---|---|
| Age (years) | ||
| Mean (SD) | 30.7 (6.4) | 30.0 (15.5) |
| Median (1st-3rd Q) | 29.5 (26.8-32.2) | 26.0 (20.0-34.0) |
| Sex (M/F) | 3/15 | 8/12 |
| Harvey Index | – | 7.7 ± 3 |
| CRP [0-8 mg/L] | ||
| Mean (SD) | 1.4 (1.9) | 52.5 (47.9) |
| Median (1st-3rd Q) | 1 (0.7-1.4) | 47.0 (9.5-90.1) |
| Fibrinogen [170-437 mg/dL] | ||
| Mean (SD) | 318.4 (92.0) | 485.3 (79.2) |
| Median (1st-3rd Q) | 304.0 (247.8-338.0) | 485.0 (428.5-527.5) |
| Leukocytes [4.5-10.8 × 103/µL] | ||
| Mean (SD) | 5.8 (1.3) | 9.7 (5.9) |
| Median (1st-3rd Q) | 5.6 (4.8-6.4) | 8.6 (4.8-13.7) |
| Lymphocytes [2.0-11.0 × 103/µL] | ||
| Mean (SD) | 2.0 (0.4) | 1.8 (0.8) |
| Median (1st-3rd Q) | 2.0 (1.7-2.3) | 1.8 (1.1-2.3) |
| S/nS/eS | 4/14/0 | 7/12/1 |
| Clinical classification of CD (montreal classification) | ||
| A (age at diagnosis, years) | ||
| A1 (≤16) | 2 | |
| A2 (17–40) | 14 | |
| A3 (>40) | 4 | |
| L (location) | ||
| L1 (ileal) | 11 | |
| L2 (colonic) | 2 | |
| L3 (ileocolonic) | 7 | |
| L4 (upper GI disease) | 0 | |
| B (behaviour) | ||
| B1 (inflammatory) | 15 | |
| B2 (structuring) | 5 | |
| B3 (penetrating) | 0 | |
| P (perianal) | ||
| Yes | 5 | |
| No | 15 | |
Abbreviations: CRP, C-reactive protein; GI, gastrointestinal; S/nS/eS, smokers, non-smokers, ex-smokers.
| . | Control (n = 18) . | Onset CD (n = 20) . |
|---|---|---|
| Age (years) | ||
| Mean (SD) | 30.7 (6.4) | 30.0 (15.5) |
| Median (1st-3rd Q) | 29.5 (26.8-32.2) | 26.0 (20.0-34.0) |
| Sex (M/F) | 3/15 | 8/12 |
| Harvey Index | – | 7.7 ± 3 |
| CRP [0-8 mg/L] | ||
| Mean (SD) | 1.4 (1.9) | 52.5 (47.9) |
| Median (1st-3rd Q) | 1 (0.7-1.4) | 47.0 (9.5-90.1) |
| Fibrinogen [170-437 mg/dL] | ||
| Mean (SD) | 318.4 (92.0) | 485.3 (79.2) |
| Median (1st-3rd Q) | 304.0 (247.8-338.0) | 485.0 (428.5-527.5) |
| Leukocytes [4.5-10.8 × 103/µL] | ||
| Mean (SD) | 5.8 (1.3) | 9.7 (5.9) |
| Median (1st-3rd Q) | 5.6 (4.8-6.4) | 8.6 (4.8-13.7) |
| Lymphocytes [2.0-11.0 × 103/µL] | ||
| Mean (SD) | 2.0 (0.4) | 1.8 (0.8) |
| Median (1st-3rd Q) | 2.0 (1.7-2.3) | 1.8 (1.1-2.3) |
| S/nS/eS | 4/14/0 | 7/12/1 |
| Clinical classification of CD (montreal classification) | ||
| A (age at diagnosis, years) | ||
| A1 (≤16) | 2 | |
| A2 (17–40) | 14 | |
| A3 (>40) | 4 | |
| L (location) | ||
| L1 (ileal) | 11 | |
| L2 (colonic) | 2 | |
| L3 (ileocolonic) | 7 | |
| L4 (upper GI disease) | 0 | |
| B (behaviour) | ||
| B1 (inflammatory) | 15 | |
| B2 (structuring) | 5 | |
| B3 (penetrating) | 0 | |
| P (perianal) | ||
| Yes | 5 | |
| No | 15 | |
| . | Control (n = 18) . | Onset CD (n = 20) . |
|---|---|---|
| Age (years) | ||
| Mean (SD) | 30.7 (6.4) | 30.0 (15.5) |
| Median (1st-3rd Q) | 29.5 (26.8-32.2) | 26.0 (20.0-34.0) |
| Sex (M/F) | 3/15 | 8/12 |
| Harvey Index | – | 7.7 ± 3 |
| CRP [0-8 mg/L] | ||
| Mean (SD) | 1.4 (1.9) | 52.5 (47.9) |
| Median (1st-3rd Q) | 1 (0.7-1.4) | 47.0 (9.5-90.1) |
| Fibrinogen [170-437 mg/dL] | ||
| Mean (SD) | 318.4 (92.0) | 485.3 (79.2) |
| Median (1st-3rd Q) | 304.0 (247.8-338.0) | 485.0 (428.5-527.5) |
| Leukocytes [4.5-10.8 × 103/µL] | ||
| Mean (SD) | 5.8 (1.3) | 9.7 (5.9) |
| Median (1st-3rd Q) | 5.6 (4.8-6.4) | 8.6 (4.8-13.7) |
| Lymphocytes [2.0-11.0 × 103/µL] | ||
| Mean (SD) | 2.0 (0.4) | 1.8 (0.8) |
| Median (1st-3rd Q) | 2.0 (1.7-2.3) | 1.8 (1.1-2.3) |
| S/nS/eS | 4/14/0 | 7/12/1 |
| Clinical classification of CD (montreal classification) | ||
| A (age at diagnosis, years) | ||
| A1 (≤16) | 2 | |
| A2 (17–40) | 14 | |
| A3 (>40) | 4 | |
| L (location) | ||
| L1 (ileal) | 11 | |
| L2 (colonic) | 2 | |
| L3 (ileocolonic) | 7 | |
| L4 (upper GI disease) | 0 | |
| B (behaviour) | ||
| B1 (inflammatory) | 15 | |
| B2 (structuring) | 5 | |
| B3 (penetrating) | 0 | |
| P (perianal) | ||
| Yes | 5 | |
| No | 15 | |
Abbreviations: CRP, C-reactive protein; GI, gastrointestinal; S/nS/eS, smokers, non-smokers, ex-smokers.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
